⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30018224 | 0.72 | USP2 (0.44) | — | |
| SCHEMBL537775 | 0.69 | — | — | |
| SCHEMBL14779541 | 0.69 | USP2 (0.41) | — | |
| SCHEMBL14779833 | 0.67 | USP2 (0.33) | — | |
| SCHEMBL1259458 | 0.67 | USP2 (0.33) | — | |
| SCHEMBL538590 | 0.63 | ALDH1A1 (0.41) | — | |
| SCHEMBL9898501 | 0.63 | CA2 (0.35) | — | |
| SCHEMBL14779803 | 0.63 | ALDH1A1 (0.41) | — | |
| SCHEMBL14778593 | 0.63 | USP2 (0.35) | — | |
| SCHEMBL14779831 | 0.63 | USP2 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6392032-B1 | COMPOUND FOR USE AS A MODULATOR OF PLANT PROPAGATION; FOR USE AS HERBICIDE; FOR USE AS ANTITUMOR AGENT | BOARD OF REGENTS UNIVERSITY OF NEBRASKA-LINCOLN | 2002-05-21 | — | — | US | disclosed |
| US-6013790-A | Heavily fluorinated sugar analogs | BOARD OF REGENTS UNIVERSITY OF NEBRASKA-LINCOLN (US) | 2000-01-11 | — | — | US | disclosed |
| US-5821357-A | REACTING ALPHA-ANOMER ENRICHED 2,2-DIFLUOROCARBOHYDRATE WITH AT LEAST TWO MOLAR EQUIVALENTS OF METAL DERIVATIVE OF NUCLEOBASE IN LOW FREEZING INERT SOLVENT | ELI LILLY AND COMPANY (US) | 1998-10-13 | — | — | US | disclosed |
| US-5744597-A | Stereoselective anion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides | ELI LILLY AND COMPANY (US) | 1998-04-28 | — | — | US | disclosed |
| US-5648473-A | GLYCOSYLATION IN SOLVENT | ELI LILLY AND COMPANY (US) | 1997-07-15 | — | — | US | disclosed |
| US-5644043-A | ANTITUMOR, ANTICANCER, TREATMENT OF HERPES | ELI LILLY AND COMPANY (US) | 1997-07-01 | — | — | US | disclosed |
| US-5606048-A | REACTING A CONCENTRATED ALPHA- OR BETA-ANOMER ENRICHED 1-DEOXY-2,2-DIFLUOROCARBOHYDRATE OR 2-DEOXY-2-FLUOROCARBOHYDRATE WITH A MOLAR EQUIVALENT OF A NUCLEOBASE DERIVATIVE IN A HIGH BOILING INERT SOLVENT | ELI LILLY AND COMPANY (US) | 1997-02-25 | — | — | US | disclosed |
| US-5594124-A | REACTING ALPHA-ANOMER ENRICHED 2,2-DIFLUOROCARBOHYDRATE WITH AT LEAST THREE MOLAR EQUIVALENTS OF PROTECTED NUCLEOBASE IN LOW FREEZING INERT SOLVENT | ELI LILLY AND COMPANY (US) | 1997-01-14 | — | — | US | disclosed |
| US-5574021-A | LEUKEMIA | ELI LILLY AND COMPANY (US) | 1996-11-12 | — | — | US | disclosed |
| US-5464826-A | Antitumor, anticarcinogenic agents, treatment of herpes | ELI LILLY AND COMPANY (US) | 1995-11-07 | — | — | US | disclosed |
| CN-1020194-C | Process for preparation of difluoronucleoside derivatives | LILLY CO ELI (US) | 1993-03-31 | — | — | CN | disclosed |
| US-5118820-A | Carbohydrate is chemical intermediate for nucleoside | ELI LILLY AND COMPANY (US) | 1992-06-02 | — | — | US | disclosed |
| US-5061793-A | Antitumor agents | ELI LILLY AND COMPANY (US) | 1991-10-29 | — | — | US | disclosed |
| US-5015743-A | 2-Deoxy-2,2-difluororibose | ELI LILLY AND COMPANY (US) | 1991-05-14 | — | — | US | disclosed |
| US-4983724-A | Oxidation, stereoselective reduction with hydride, hydroxy protecting groups | ELI LILLY AND COMPANY (US) | 1991-01-08 | — | — | US | disclosed |
| US-4808614-A | Difluoro antivirals and intermediate therefor | ELI LILLY AND COMPANY (US) | 1989-02-28 | — | — | US | disclosed |
| US-4692434-A | NUCLEOSIDES | ELI LILLY AND COMPANY (US) | 1987-09-08 | — | — | US | disclosed |
| EP-0211354-A2 | Nucleosides and their use as antineoplastic agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1987-02-25 | — | — | EP | disclosed |
| CN-85109409-A | Improvements in the treatment of mammalian tumors | — | 1986-08-27 | — | — | CN | disclosed |
| US-4526988-A | Hydrolyzing alkyl 3-dioxolanyl-2,2-difluoro-3-hydroxy propionate | ELI LILLY AND COMPANY (US) | 1985-07-02 | — | — | US | disclosed |